- Current report filing (8-K)
May 11 2009 - 10:26AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
May 11, 2009
AVIGEN, INC.
(Exact name of registrant as specified in charter)
Delaware
|
000-28272
|
13-3647113
|
(State or other jurisdiction of
|
(Commission File Number)
|
(I.R.S. Employer Identification
|
incorporation)
|
|
No.)
|
1301 Harbor Bay Parkway
Alameda,
California 94502
(Address of principal
executive offices and zip code)
Registrants telephone number, including
area code:
(510) 748-7150
_____________________________
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and
Financial Condition.
On
May 11, 2009
,
Avigen, Inc. issued a press release announcing its financial results for the
quarter ended March 31, 2009
. A copy of the press release is attached as Exhibit 99.1 to
this current report and is incorporated herein by reference.
The information in this Section 2.02 and in the press release attached as
Exhibit 99.1 to this current report, shall not be deemed to be filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2)
of the Securities Act of 1933, as amended. The information contained in this
Section 2.02 and in the accompanying exhibit shall not be incorporated by
reference into any filing with the U.S. Securities and Exchange Commission made
by Avigen, Inc., whether made before or after the date hereof, regardless of any
general incorporation language in such filing.
Item 9.01 Financial Statements and
Exhibits.
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release, dated
May 11,
2009
, announcing Avigens financial results
for the quarter ended March 31, 2009
.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
Dated: May 11,
2009
|
A
VIGEN
,
I
NC
.
|
|
|
By:
|
/s/ ANDREW A.
SAUTER
|
|
|
Andrew A.
Sauter
|
|
|
Chief Executive Officer, President and
|
|
|
Chief Financial Officer
|
INDEX
TO
EXHIBITS
Exhibit
Number
|
|
Description
|
99.1
|
|
Press Release, dated May 11, 2009, announcing Avigens financial
results for the quarter ended March 31, 2009
.
|
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jul 2023 to Jul 2024